netFormulary NHS
NHS NEL
Demonstration Formulary
 Search
 Formulary Chapter 5: Infections - Full Section
Notes:

This formulary indicates prescribing status only, for guidance on managing infections please refer to your local antibiotic guidelines

Summary of antimicrobial prescribing guidance - managing common infections

 Useful Links
Numbers in brackets indicate counts of (Formulary items, Non Formulary items)
05.01 Antibacterial drugs (4,2)
05.01.01 Penicillins (0,0)
05.01.01.01 Benzylpenicillin and phenoxymethylpenicillin (4,0)
05.01.01.02 Penicillinase-resistant penicillins (4,0)
05.01.01.03 Broad-spectrum penicillins (4,4)
05.01.01.04 Antipseudomonal penicillins (1,0)
05.01.01.05 Mecillinams (1,1)
05.01.02 Cephalosporins, carbapenems and other beta-lactums (0,0)
spacespace Other beta-lactam antibiotics (0,0)
05.01.02.01 Cephalosporins (12,10)
05.01.02.02 Carbapenems (6,1)
05.01.02.03 Other beta-lactums antibiotics (1,1)
05.01.03 Tetracyclines (5,4)
spacespace Tigecycline (1,0)
05.01.04 Aminoglycosides (10,3)
05.01.05 Macrolides (7,8)
05.01.06 Clindamycin (2,2)
05.01.07 Some other antibacterials (3,0)
spacespace Chloramphenicol (1,0)
spacespace Fosfomycin (0,0)
spacespace Fusidic acid (3,0)
spacespace Vancomycin and teicoplanin (3,0)
spacespace Daptomycin (1,1)
spacespace Linezolid (2,1)
spacespace Quinupristin and dalfopristin (0,1)
spacespace Polymyxins (5,0)
spacespace Rifaximin (1,0)
spacespace Fidaxomicin (1,1)
05.01.08 Sulphonamides and trimethoprim (4,0)
05.01.09 Antituberculosis drugs (17,0)
05.01.10 Antileprotic drugs (3,0)
05.01.11 Metronidazole and tinidazole (3,1)
05.01.12 Quinolones (7,3)
05.01.13 Urinary-tract infections (5,5)
05.02 Antifungal drugs (7,1)
05.02.01 Triazole antifungals (7,0)
05.02.02 Imidazole antifungals (1,0)
05.02.03 Polyene antifungals (2,0)
05.02.04 Echinocandin antifungals (3,0)
05.02.05 Other antifungals (3,1)
05.03 Antiviral drugs (4,0)
05.03.01 HIV infection (0,1)
spacespace Nucleoside reverse transcriptase inhibitors (20,11)
spacespace Protease inhibitors (14,6)
spacespace Non-nucleoside reverse transcriptase inhibitors (4,1)
spacespace Other antiretrovirals (6,1)
spacespace Pharmacokinetic enhancers of antiretrovirals (1,0)
spacespace Combination Products (0,0)
05.03.02 Herpesvirus infections (1,0)
05.03.02.01 Herpes simplex and varicella-zoster infection (5,0)
05.03.02.02 Cytomegalovirus infection (7,0)
05.03.03 Viral hepatitis (3,0)
05.03.03.01 Chronic hepatitis B (2,1)
05.03.03.02 Chronic hepatitis C (5,1)
05.03.04 Influenza (5,1)
05.03.05 Respiratory syncytial virus (2,0)
05.04 Antiprotozoal drugs (30,11)
05.04.01 Antimalarials (0,0)
spacespace Treatment of malaria (0,0)
spacespace Artemether with lumefabtrine (1,1)
spacespace Chloroquine (0,1)
spacespace Mefloquine (0,0)
spacespace Primaquine (1,0)
spacespace Proguanil (1,1)
spacespace Pyrimethamine (0,0)
spacespace Quinine (1,0)
spacespace Tetracyclines (0,0)
05.04.02 Amoebicides (0,2)
05.04.03 Trichomonacides (0,0)
05.04.04 Antigiardial drugs (1,0)
05.04.05 Leishmaniacides (0,0)
05.04.06 Trypanocides (0,0)
05.04.07 Drugs for toxoplasmosis (1,0)
05.04.08 Drugs for pneumocystis pneumonia (1,0)
05.05 Anthelmintics (16,1)
05.05.01 Drugs for threadworms (0,0)
05.05.02 Ascaricides (0,0)
05.05.03 Drugs for tapeworm infections (0,0)
spacespace Taenicides (0,0)
spacespace Hydatid disease (0,0)
05.05.04 Drugs for hookworms (0,0)
05.05.05 Schistosomicides (0,0)
05.05.06 Filaricides (0,0)
05.05.07 Drugs for cutaneous larva migrans (0,0)
05.05.08 Drugs for strongyloidiasis (0,0)
netFormulary